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Objective: The pathogenesis of osteoarthritis (OA) is not fully understood, but bone changes are sug-
gested to be important. Bone turnover and bone volume (BV) in human hip OA were investigated in
relation to the overlying cartilage degeneration using design-based stereological estimators.
Materials and Methods: Femoral heads were obtained from 25 end-stage OA patients and 24 controls
(CTL). Design-based stereological methods were used for sampling and quantiﬁcation to obtain absolute
estimates of volume and surface in the central trabecular and the subarticular bone region. The sub-
articular bone was further subdivided into regions according to the OARSI-score of the overlying articular
cartilage in which erosion and osteoid surfaces were estimated.
Results: In the subarticular region, bone volume (BV/TV) was 15.0% higher in OA patients compared to
CTL; The fraction of erosive (ES/BS) and osteoid surfaces (OS/BS) were 56.2% and 72.8% higher in OA
compared to CTL. In subarticular regions with none to mild cartilage degeneration (OARSI grade 0e2), ES/
BS and OS/BS were 48.6% and 59.9% higher in OA compared to CTL, whereas BV/TV did not differ between
OA and CTL.
Conclusion: In human end-stage hip OA, BV and bone turnover correlate with the degree of local cartilage
degeneration. Subarticular bone sclerosis was only present in regions corresponding to end-stage OA.
However, in regions with only none to mild cartilage degeneration the underlying bone had signiﬁcantly
higher turnover in OA patients compared to the control group, suggesting that high bone turnover may
contribute to the early pathogenesis of OA.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a degenerative disease of the joints. The
prevalence is 20e40% for the population aged more than 45 years1.
No disease modifying drugs are available, and treatment of end-
stage OA is limited to arthroplasty.
Radiologically, end-stage OA is characterized by thinning of the
articular cartilage, osteophyte formation, and subchondral bone
sclerosis2,3. In patients with early-stage OA, changes in theE.-M. Hauge, Department of
rogade 44, 8000 Aarhus C,
ternational. Published by Elsevier Lsubchondral bone has been observed to occur before cartilage
loss4e6, however in these studies an early thinning of the sub-
chondral bone plate was found7. It has also been demonstrated in
animal studies that thinning of the subchondral bone occurred
before cartilage damage was detected8e10, suggesting that bone
turnover may be increased in the early stages of OA leading to net
bone resorption that may be followed by net bone formation in
later stages of OA. Furthermore, osteophyte formation caused by
endochondral ossiﬁcation of the mature skeleton11 is a character-
istic feature of both experimental and clinical OA12. These obser-
vations of two possible mechanisms of bone formation in OA have
led to the hypothesis that OA is a disease of excessive bone for-
mation, and therefore targeting the bone metabolism could
possibly inhibit OA progression13e15.td. All rights reserved.
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and the studies investigating bone are predominately radio-
graphical and lack information about bone turnover. Using design-
based stereology, which samples the entire joint uniform randomly
and includes severe as well as subtle changes, we quantiﬁed bone
volume (BV) and bone turnover in relation to the overlying cartilage
degeneration in human hip OA. In this study on human femoral
heads, it was hypothesized that BV and bone turnover would be
higher in regions with severe cartilage degradation.
Methods
Study population
The study population consisted of 49 entire femoral heads.
Twenty-ﬁve femoral heads were obtained from patients with end-
stage primary hip OA, whowent through joint replacement surgery
of the hip at the Department of Orthopedics at Farsoe Hospital,
Denmark. The patients had a mean age of 64 ± 7.3 yr, and met the
criteria from the American College of Rheumatology for OA12. All
Patients had a KellgreneLawrence grade of at least 3 (Table I). Pa-
tients with known bone metabolic diseases, secondary OA or other
joint diseases, diabetes mellitus (DM), or malignant diseases were
excluded.
Twenty-four femoral heads were obtained from a sex- and age-
matched control group (61.5 ± 7.98 yr) of individuals, who died
suddenly from accidents or acute diseases. These femoral heads
were collected from the Institute of Forensic Medicine, Aarhus
University. Individuals with high-energy pelvic trauma or signs of
hip OA after macroscopic inspection were excluded. Controls were
also excluded if they had any known diagnosis of bone metabolic
disease, other joint diseases, DM, or malignant diseases.
The study was approved by The Regional Scientiﬁc Ethical
Committee (J.nr: 200337723) and The Danish Data Protection
Agency (J.nr: 2003-41-3447).
Processing of tissue
The procedure for preparing the tissue according to the criteria
of stereological sampling, and the principles for counting have
previously been described in detail16. In short: The femoral heads
were ﬁxed in 70% ethanol, and then processed by the principles of
vertical uniform random (VUR) sections17. The femoral head was
randomly rotated (Fig. 1A) and cut by a diamond saw parallel to a
vertical axis through the top of the femoral head producing ﬁve to
eight 7-mm-thick bone slabs (Fig. 1B). The bone slabs were thenTable I
Characteristics of OA patients and healthy controls
Clinical characteristics
Age (years, mean ± SD)
No. of men/women
KellgreneLawrence score
WOMAC Normalized NRS 3.0 (mean ± SD)
Histological staging of OA
Percentage of subarticular region with overlying none to mild cartilage lesions (%)
Percentage of subarticular region with overlying moderate cartilage lesions (%)
Percentage of subarticular region with overlying severe cartilage lesions (%)
x P ¼ <0.001 vs CTL.
* Comprised of four CTL.
y Comprised of one CTL.sawn into a right and left half and embedded in methylmetacrylate
(Fig. 1C). Seven mm thick sections were cut from alternating left and
right half bone slabs, the ﬁrst being chosen at random, using a Jung
model Kmicrotome (R. Jung GmbHHeidelberg, Germany) equipped
with a tungsten microtome knife. The sections were stained with
Masson-Goldner trichrome for stereological analysis (Fig. 1D).
Deﬁnition of tissue structures
The term subchondral bone is ambiguous18. In this study the
subchondral bone was deﬁned as the bone separating the articular
cartilage from the marrow as judged by the two-dimensional his-
tology slides. To investigate the correlation between bone turnover
and cartilage degeneration an arbitrary subarticular bone region
was deﬁned, which included both subchondral and cancellous bone
and was deﬁned as a 5 mm thick zone below the tidemark. BV was
measured within this same region.
This subarticular bone region of the femoral head was sub-
divided according to the degeneration of the overlying articular
cartilage, irrespectively of the regions being weight-bearing.
Cartilage damage was scored using The Osteoarthritis Research
Society International (OARSI) osteoarthritis cartilage histopathol-
ogy assessment system19, and grouped as normal-mild (OARSI
0e2), moderate (OARSI 3e4) or, in case of complete hyaline carti-
lage loss, as severe (OARSI 5e6). Osteophytes were not included
(Fig. 2).
Stereology
Data were collected with the use of a light microscope (Nikon
Eclipse 80i, Tokyo, Japan) equipped with a motorized specimen
stage (Prior Proscan 11 TM, Rockland, MA, USA), a microcator
(Heidenhain MT 1201, Traunreut, Germany) and a digital video
camera (OlympusDP72, Tokyo, Japan) connected to a PC running
the newCAST interactive stereology software (v. 3.4.1.0, Visiopharm,
Hørsholm, Denmark). Test-points and test-lines were super-
imposed to the digital images of the tissue sections and viewed on
the PC monitor with a total magniﬁcation of  290.
Both BV and tissue volume (TV) were estimated by Cavalieri's
estimator20,21. For bone and TV, a grid constant with an area per
point (a(P)) of respectively 0.05 mm2 and 0.47 mm2 was used. The
estimated parameters for bone turnover were absolute osteoid
surface (OS), erosive surface (ES), and quiescent surface (QS). Sur-
face estimationwas done using a line probe with an area per length
(a(l)) of 0.79 mm17. Bone volume was calculated as the percentage
of bone volume relative to the absolute TV (BV/TV%) and theOA patients (n ¼ 25) CTL (n ¼ 24)
64 ± 7.3 61.5 ± 8.0
12/13 12/12
KL#1 0 e
KL#2 0 e
KL#3 4 e
KL#4 21 e
Pain 50 ± 21 e
Stiffness 56 ± 29 e
Physical Function 44 ± 14 e
59.4 ± 21.5 98.5 ± 4.2x
15.5 ± 7.7 1.4 ± 4.1x*
25.1 ± 21.2 0.1 ± 0.42xy
Fig. 1. Design-based stereological methods. Using systematic uniform random sampling, the Cavalieri estimator and vertical sections to investigate entire undecalciﬁed human
femoral heads. (A): the femoral heads random section was chosen by random rotation of the femoral head around the vertical axis. The red arrow hits the random number 27. (B):
black lines indicate the 7-mm thick slices parallel cuts. (C): half block 7-mm thick slices were embedded in plastic. (D): From each plastic block, 7-mm-thick sections were cut on the
microtome and stained with Masson-Goldner trichrome.
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tive to the absolute bone surface area (BS). Bone volume to bone
surface (BV/BS) and bone surface to tissue volume (BS/TV) was also
calculated. The precision of the volume estimates were calculated
using the Coefﬁcient of Error (CE)21e23, CE(V)TV ¼ 0.044 and
CE(V)BV ¼ 0.041. CE for surface estimates were not calculated,
because no CE formula for surfaces has been validated16.
Statistics
Data were analyzed using STATA 12 (StataCorp LP, College sta-
tion, TX, USA). Groups were compared with one-way ANOVA. If the
hypothesis of equal means in the groups were rejected, pair wise
comparisons between groups were made. Normality was checked
with QQ-plots, and ShapiroeWilk test. If data was normally
distributed, Student's t test was used to compare two groups;
otherwise, ManneWhitney rank sum test was applied. The data are
presented as median (25-75-percentiles). P-values less than 0.05
were considered statistically signiﬁcant.
Results
The OARSI-staging19 of the femoral heads of both OA patients
and CTL are reported in Table I as the volume percentage of thesubarticular regions (Fig. 2) with the overlying cartilage scored
according to the OARSI-grade 0e2 (none to mild), 3e4 (moderate),
and 5e6 (severe).
In the subarticular bone region, the average BV/TV was statis-
tically signiﬁcantly higher in OA patients than in CTL (Fig. 3A).
However, when subdividing the subarticular bone region according
to the overlying cartilage degeneration, BV/TV did not differ be-
tween OA and CTL in regions with none to mild cartilage degen-
eration, (Table II).
The estimates for bone turnover, ES/BS and OS/BS, were both
statistically signiﬁcantly higher in OA patients compared to CTL in
the subarticular bone region (Fig. 3BeC). In the regionwith none to
mild cartilage degeneration, ES/BS and OS/BS was also signiﬁcantly
higher in OA patients than in CTL (Table II).
In the central region of the femoral head, BV/TV showed no
difference between OA and CTL (Fig. 4A), whereas both ES/BS and
OS/BS in OA patients was statistically signiﬁcantly higher than in
CTL (Fig. 4BeC).
The ratio between the osteoid surface and erosive surface (OS/
ES) for OA patients compared to CTL was signiﬁcantly higher in the
subarticular bone region (Fig. 3D), and also in the central bone
region (Fig. 4D).
The subarticular bone region had a signiﬁcantly higher BV/BS in
OA patients compared to CTL. In the central bone region however,
Fig. 2. Goldner-trichrome stained vertical uniform random sections of a half femoral
head divided into subarticular bone regions according to overlying cartilage degen-
eration OARSI 0e2 (green), OARSI 3e4 (blue), OARSI 5e6 (red), and central bone region
(yellow).
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cantly different between OA patients and CTL, neither in the sub-
articular bone region nor the central bone region.Discussion
This is the ﬁrst cross-sectional study investigating bone turn-
over in relation to the severity of articular cartilage degeneration in
the entire femoral head from end-stage OA patients and CTL
applying design-based stereology. Subarticular bone turnover, butFig. 3. Bone volume, erosive and osteoid surface from the subarticular bone region of the
median and interquantile range of the groups. Non-parametric test was used in C and D wnot bone mass, was higher in OA patients compared to CTL in re-
gions with none or mild local cartilage lesions. Bone turnover were
increasingly higher in association with overlying cartilage degen-
eration in OA patients. Higher bone volume however, was found
only in subarticular regions with moderate to complete hyaline
cartilage loss.
Sclerotic subchondral bone is a characteristic of OA24,25. How-
ever, studies have demonstrated that while bone volume is higher
in the weight-bearing regions of OA patients compared to CTL, the
bone volume is lower in the non-weight-bearing regions26, which
could be a result of a changed bone turnover. The present study
sampling entire human osteoarthritic femoral heads did not focus
at regions of different weight-bearing, but at regions of different
cartilage degradation, and it was found that bone volume was
higher in regions with more severe cartilage destruction. This is in
line with a previous study of knee OA24,27. It is however also known
that weight-bearing regions are those most severely affected by
cartilage degeneration28.
The lack of focal bone sclerosis in regions with overlying mild
cartilage lesions, does not point towards bone sclerosis as an
initiating factor for OA25. Microcracks in the calciﬁed cartilage and
subchondral bone have been suggested to reactivate a secondary
ossiﬁcation center leading to endochondral ossiﬁcation and
increased by bone turnover29. Microcracks were not investigated in
the present study, but we did ﬁnd indications of an increased bone
turnover in OA patients as suggested by the higher bone resorptive
surfaces and bone formative surfaces in the subarticular regions in
OA patients compared to CTL. In experimental studies, OS and ES
are also higher in osteoarthritic joints30. Inhibiting bone resorption
in surgically induced OA mice protects against cartilage degenera-
tion, which is most likely due to the coupling between formation
and resorption in bone remodelling31. In rats, it has been shown
that pre-emptive alendronate treatment before surgically induced
OA almost completely prevented the loss of cartilage pointing to-
wards bone tissue playing a major role in OA pathogenesis.
Few studies have investigated local bone turnover in human OA.
One study showed a higher OS/BS but not ES/BS in OA patients
compared to CTL, in a weight-bearing region of the subchondral
bone, but not in the non-weight-bearing region26, which is some-
what in disagreement with the present study, since both OS/BS and
ES/BS were higher in OA compared to CTL in all subarticular re-
gions. It may suggest that all regions are inﬂuenced by processes
ultimately leading to OA, whereas some regions are prone to local
factors accelerating the process such as weight-bearing. In this
context, regions with mild-moderate cartilage degeneration may
represent early OA lesions, and regions with severe cartilage
degeneration may represent late OA lesions. Furthermore, highfemoral head in both osteoarthritic patients and the control group. Boxes denotes the
hich was not normally distributed.
Table II
Comparison of bone volume (BV/TV), bone resorption (ES/BS), and bone formation (OS/BS) betweenOA patients and CTL in subarticular regionswith none tomild (OARSI 0e2),
moderate (OARSI 3e4), or severe (OARSI 5e6) cartilage lesions
OA CTL
None to mild Moderate Severe None to mild
BV/TV%* 24.1 (21.9e28.6) 38.8 (29.7e43.3)y 43.6 (35.2e50.5)y,z 24.7 (23.4e28.8)
ES/BS%* 7.4 (5.9e9.7) 9.7 (5.4e12.9)k 15.8 (10.2e19.9)y,z 4.3 (3.2e5.0)x
OS/BS%* 10.8 (7.3e13.8) 13.8 (10.3e23.7)y 27.5 (20.9e36.8)y,z 2.5 (1.7e3.8)x,k
OS/ES 1.3 (1.0e1.6)k 1.6 (1.3e2.1) 2.0 (1.3e2.7) 0.6 (0.4e1.0)x,k
BV/BS mm* 0.017 (0.016e0.019)k 0.029 (0.025e0.033)y 0.022 (0.019e0.029)y,z,k 0.018 (0.015e0.020)
BS/TVmm1 13.3 (12.8e14.7) 14.9 (13.9e16.6) 14.06 (13.1e15.8) 14.3 (13.1e15.6)
Data are expressed as median and inter-quartile range.
* Represent statistical signiﬁcance at P < 0.001 using analysis of variance (ANOVA) of different subarticular sub-regions in OA patients.
y Represent statistical signiﬁcance at P < 0.05 difference between none to mild and either moderate or severe.
z Represent statistical signiﬁcance at P < 0.05 difference with moderate.
x Represent statistical signiﬁcance at P < 0.05 between the same sub-regions between OA and CTL.
k Represent group that tested negative for normal distribution.
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cartilage damage is characterized by focal and superﬁcial ﬁbrilla-
tion only. This is supported by the observation of high bone turn-
over also in the central region, suggesting that OA patients have a
higher bone turnover in general. This is in line with an experi-
mental study, which demonstrated an increased trabecular bone
remodelling in the femoral head in early OA32.
In a clinical study, it has been shown that postmenopausal
women with progressive knee OA had increased systemic bone
resorption compared to healthy individuals. Urine analysis showed
that osteoporosis patients and OA patients were not signiﬁcantly
different when measuring N- and C-terminal of Type I collagen
telopeptides representing bone resorption33. The study did not
include biomarkers of bone formation, however from other studies
it has been observed that osteocalcin is higher in OA compared to
osteoporosis34. The higher biomarkers for bone metabolism also
suggest that OA patients have excessive bone metabolism in gen-
eral, it should however be noted that the study only included bio-
markers for bone resorption, and not bone formation.
The femoral head is found tobe larger inOApatients compared to
controls35,36, and it has been observed in one radiologic study, that
the femoral head increases with age37. It is not known if the size
increases more with age in OA patients compared to healthy in-
dividuals, however an increased size of the femoral head could
possibly contribute to cartilage damage, either because of a shift in
pressure on the cartilage and bone or because of bone growth into
cartilage by endochondral ossiﬁcation. In this study, an increased
growth of the femoral head in OA patients may be indicated by the
signiﬁcantly higher ratio betweenOS and ES and higher BV/BS in theFig. 4. Bone volume, erosive and osteoid surface from the central bone region of the femora
and interquantile range of the groups. Non-parametric test was used in C and D which wasubarticular bone region indicating a thicker subarticular bone inOA
compared to CTL. Assuming that OA patients have similar bone
remodelling period as healthy individuals, this points towards an
adaptation of bone remodelling in favour of bone formation. Radial
growth of the femoral head would also require endochondral ossi-
ﬁcation to occur at the tidemark, and bonemodelling to occur at the
cement line. Combined with previous studies showing that OA
joints have an increased trabecular and subchondral thickness, and
higher volume of the femoral head37,38, supports the theory that OA
is a disease characterized not only by decay, but also by growth39,40.
OS and ES were used as an indication for bone turnover. How-
ever these are only truly representative, if the bone remodelling
period is the same in OA as in healthy individuals. The rate of bone
resorption cannot be investigated directly, and the bone formation
rate can only be estimated if ﬂuorescence labels are introduced,
which was not possible in the control group. In this study, patients
with DM were excluded, the metabolic effect that DM inﬂicts on
bone41 therefore have not impacted on the observed differences in
bone volume and bone turnover.
Bone cannot be fully understood in two-dimensional terms. In
this study, it was possible to get quantitative data of a 3D structure
by using the sampling tools of design-based stereology42. By the
use of this technique, the femoral head was investigated as a
complete architectural structure, instead of studying small samples
of the most severely affected locations. We did not have the op-
portunity to study bone and cartilage samples from patients with
lower radiological OA grades. If patients with end-stage OA repre-
sent individuals with a predisposed risk for developing OA with
different degrees of focal changes, then regions with mild lesionsl head in both osteoarhritic patients and the control group. Boxes denotes the median
s not normally distributed.
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ences in load may impact on both cartilage degeneration and bone
remodelling26,43. It should be noted that bone remodelling has been
shown to be different in OA patients compared to healthy in-
dividuals both systemically33, and locally in bone site not being
loaded such as the iliac crest where bone formationwhere higher in
OA patients compared to healthy individuals26,44.
In conclusion, using design-based stereological estimators on
entire human femoral heads, we found that bone turnover was
increased in both subchondral and trabecular bone in the femoral
head, even in the subarticular regions with overlying mild cartilage
damage. However, bone volume was not increased in these sub-
articular regions with mild cartilage damage, and increased bone
volume was seen only in the regions with moderate or complete
hyaline cartilage loss. Therefore, in human OA, increased bone
turnover may be an early pathogenic event, whereas subchondral
bone sclerosis is more likely a later event.
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